Safe Harbor Statement  |   Investor relations  |   News  |   Contact info      

 
Recent News
 

June 10, 2008
May 23, 2008
April 24, 2008
January 31, 2008
January 16, 2008
December 1, 2007
November 15, 2007
October 26, 2007
September 25, 2007
September 21, 2007



 Created by: AeroWeb
 Boston Web Design - Web Hosting

September 25, 2007 - Cure Lab, Inc. submits a provisional patent application on technology that allows for the increase in efficiency of vaccination with recombinant vaccines.

It is known that the naturally occurring codons of genes encoding for an antigen and/or therapeutic protein may be suboptimal. Together with computational biologists from The Technical University of Munich, Cure Lab has developed a technology that enables the codon optimization of these genes, thereby enhancing their immunogenicity.